UPDATE 3-U.S. Treasury rules put Pfizer-Allergan deal in question
NEW YORK, April 5 (Reuters) - The U.S. Treasury Department's proposed new tax regulations threw a series of corporate mergers into question on Tuesday, fanning a hot political situation and pushing Pfizer Inc closer to a decision to walk away from buying Botox maker Allergan Plc. [Source]
Publication Date:Origin: us.feedsportal.com
Category: industrialsSector
Topics: question, Treasury, Allergan, maker, Botox, buying, decision, closer, Pfizer, pushing, situation, political, fanning, mergers, corporate, series, threw, regulations, proposed, Department's, (Reuters), April, Pfizer-Allergan, rules, UPDATE